€119.00
0.58% yesterday
Paris, Jun 27, 05:35 pm CET
ISIN
FR0013280286
Symbol
BIM
Sector

bioMerieux SA Stock price

€119.00
+1.40 1.19% 1M
+16.90 16.55% 6M
+15.50 14.98% YTD
+28.80 31.93% 1Y
+27.54 30.11% 3Y
+0.00 0.00% 5Y
+87.20 274.25% 10Y
+106.45 847.96% 20Y
Paris, Closing price Fri, Jun 27 2025
-0.70 0.58%
ISIN
FR0013280286
Symbol
BIM
Sector

Key metrics

Basic
Market capitalization
€14.1b
Enterprise Value
€14.2b
Net debt
€40.9m
Cash
€449.8m
Shares outstanding
117.9m
Valuation (TTM | estimate)
P/E
32.69 | 25.66
P/S
3.56 | 3.30
EV/Sales
3.57 | 3.31
EV/FCF
44.14
P/B
3.34
Dividends
DPS
€0.90
Yield 1Y | 5Y
0.76% | 0.79%
Growth 1Y | 5Y
5.88% | 36.49%
Payout 1Y | 3Y
24.73% | 24.83%
Increased
1 Year
Financials (TTM | estimate)
Revenue
€4.0b | €4.3b
EBITDA
€647.2m | €1.0b
EBIT
€588.8m
Net Income
€432.2m | €546.9m
Free Cash Flow
€321.5m
Growth (TTM | estimate)
Revenue
8.31% | 7.59%
EBITDA
6.17% | 57.08%
EBIT
34.12%
Net Income
20.86% | 26.53%
Free Cash Flow
200.19%
Margin (TTM | estimate)
Gross
55.66%
EBITDA
16.26% | 23.73%
EBIT
14.79%
Net
10.86% | 12.77%
Free Cash Flow
8.08%
Financial Health
Equity Ratio
72.87%
Return on Equity
10.28%
ROCE
12.70%
ROIC
9.98%
Debt/Equity
0.12
More
EPS
€3.64
FCF per Share
€2.73
Short interest
-
Employees
14.45k
Rev per Employee
€280.00k
Show more

Is bioMerieux SA a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

bioMerieux SA Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a bioMerieux SA forecast:

12x Buy
71%
4x Hold
24%
1x Sell
6%

Analyst Opinions

17 Analysts have issued a bioMerieux SA forecast:

Buy
71%
Hold
24%
Sell
6%

Financial data from bioMerieux SA

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
3,980 3,980
8% 8%
100%
- Direct Costs 1,765 1,765
9% 9%
44%
2,215 2,215
8% 8%
56%
- Selling and Administrative Expenses 1,098 1,098
8% 8%
28%
- Research and Development Expense 492 492
7% 7%
12%
647 647
6% 6%
16%
- Depreciation and Amortization 58 58
66% 66%
1%
EBIT (Operating Income) EBIT 589 589
34% 34%
15%
Net Profit 432 432
21% 21%
11%

In millions EUR.

Don't miss a Thing! We will send you all news about bioMerieux SA directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. The firm develops testing. detection, and other laboratory system for the analysis of cancer, diseases, and infections caused by bacteria, virus, and fungi. The company was founded Alain Mérieux in 1963 and is headquartered in Marcy l'Etoile, France.

Head office France
CEO Pierre Boulud
Employees 14,451
Founded 1967
Website www.biomerieux.fr

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today